1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Small Business Innovation Research (SBIR) Phase I is sponsored by Small Business Administration (SBA) across various federal agencies (NIH, NSF, DOE, DOD, NASA). Provides seed funding for small businesses to conduct feasibility studies on innovative technologies with potential for commercialization. Many agencies use SBIR to fund projects that could involve decision frameworks within their specific mission areas.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Small businesses (500 employees or less) that are majority U. S. -owned and operated. Specific eligibility varies by agency and solicitation. Confirm the full requirements in the official notice before applying.
The current listing shows $100,000 - $275,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Small Business Innovation Research (SBIR) Phase I is funded by Small Business Administration (SBA) across various federal agencies (NIH, NSF, DOE, DOD, NASA). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Serial SBIR winners build cross-agency portfolios by adapting core technology to DOD, NIH, and NSF missions. Here is how they do it under the 2026 rules.
Read articleIn January 2026, DOE Policy Flash PF-2026-30 wiped out every 15% and 10% indirect cost cap the administration had imposed in 2025 — because H.R. 6938 ordered it to. The same law froze indirect policy at NSF, Commerce and NASA. But OMB's sweeping new grants rule quietly reopens the fight through the back door. Here is what changed, what money recipients can claw back, and how to protect your indirect recovery going forward.
Read articleThe FY2026 spending package preserves NIH, NSF, and DOE funding while blocking the 15% indirect cost cap. A detailed breakdown of what passed, what is next in the Senate, and how researchers should position themselves.
Read article